BILASTINE Sandoz cpr 20 mg 30 pce
7680688610055
CH-68861
R06AX29
07.13.1.
1 / 3
google
Details
- Product number
- 6886101
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- bilastinum 20 mg ut bilastinum monohydricum, cellulosum microcristallinum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, pro compresso.
Articles (1)
Bilastin Sandoz 20 mg, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 10.25
Specialties list
Yes
Generic
Yes
SL addition date:
01/01/2025
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 68861
- Drug name
- Bilastin Sandoz, Tabletten
- Galenic form
- TAB
- ATC Code
- R06AX29
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 22/09/2022
- Authorization expiration date
- 21/09/2027
- IT number
- 07.13.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BILASTINE Sandoz cpr 20 mg 30 pce
- Description (DE)
- BILASTIN Sandoz Tabl 20 mg 30 Stk
- Market launch
- 22/09/2022
- Narcotic (BTM)
- No